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Introduction: Depression is the most frequently observed psychiatric disorder among
HIV patients. The effect of depression on adherence among men who have sex with
men (MSM) HIV patients has not been well studied in the Philippines. Depression is
commonly undiagnosed and consequently untreated, which leads to a negative influence
on antiretroviral therapy (ART) adherence. Other risk factors such as HIV-related stigma,
self-body image satisfaction, and nutritional status are recognized as potential barriers
to access HIV prevention and treatment services issues and poor adherence.
Methods: Hospital anxiety and depression scale (HADS) was used to screen depressive
symptoms during scheduled clinic visits. ART adherence was self-reported using a
visual analog scale questionnaire covering the last 30 days. Structured questionnaires
were used for measuring risk factors and socio-demographic data. Anthropometry was
conducted and body composition was assessed using bioelectrical impedance analysis.
Results: One-hundred and ninety-three participants were recruited from the SHIP clinic
between 7th March and 30th September 2018, of whom, 42 (21.8%) screened positive
for depression (HADS score ≥ 8) and 24 (12.4%) were non-adherent to ART (<95% of
medication taken as prescribed). The most common reported reason for non-adherence
was simply forgotten (18 out of 42, 42.9%). Increasing depressive symptoms were
associated with non-adherence [crude odds ratio (OR) = 1.13; 95% CI: 1.02–1.26].
Social family support (SFS) and body image (BI) scores were also associated with
non-adherence, but were not statistically significant in multivariable models. Factors
significantly associated with depressive symptoms (but not non-adherence) included
the following: using intravenous drugs, being in a relationship, anxiety, self-esteem, and
stigma scores.
Conclusions: Increased depression symptoms, low social family support, and body
image dissatisfaction may be interconnected risk factors for ART non-adherence among
Filipino MSM HIV patients. Comprehensive mental health services beyond regular
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post-HIV testing counseling may increase adherence to ART and improve HIV treatment
outcomes. Further prospective studies are needed to address the causal/reverse causal
pathway between depression and non-adherence.
Keywords: depression, adherence, anxiety, antiretroviral therapy (ART), men who have sex with men (MSM),
Philippines
INTRODUCTION
The Filipino population of men who have sex with men (MSM) is
estimated to be between 200,000 and 670,000, representing 1–3%
of the total adult male population (1). The group most impacted
by HIV in the Philippines is MSM, representing 85% of new
sexually-acquired infections since 2011. The median age of new
cases is 22 years old, and more than 60% of people living with
HIV in the Philippines are under 25 (2).
The efficacy of antiretroviral therapy (ART) depends on
compliance with daily medication regimens. Adherence is
a cornerstone to suppress viral replication and improve
immunological and clinical outcomes; decrease the risk of
developing ART drug resistance; and reduce the risk of
transmitting HIV (3). A recent surveillance study in the
Philippines showed that 10.3% of patients experienced treatment
failure on their first-line regimens, possibly due to incomplete
adherence to ART (4). Also, a regional cohort study TREAT-
Asia (Therapeutic Research, Education, and AIDS Training in
Asia) found that out of 1,316 participants, 26% self-reported
suboptimal adherence levels (<95%) during their first 6 months
of treatment (5). More generally, one out of four ART users may
fail to adhere to medication for reasons which can be categorized
as relating to patient and family, medication, health delivery
system, caregiver, and social/environmental factors (6).
People living with HIV may face many challenges including
depression, low social and family support (SFS), widespread
stigma, changes in nutritional status, and barriers to accessing
mental and psychological care which may have a negative effect
on ART adherence level (7). People living with HIV are more
likely to be depressed compared with those who are HIV negative
(8), and MSM are three times more at risk of depression
compared with the general population of men (9). Depression
has a severe negative impact on the quality of life (QOL), which
can affect patient behaviors includingmedication adherence (10).
Depression in people living with HIV could be triggered by
stress, stigma, difficult life events, and side effects of medications
(11, 12). A crosssectional study in Malawi reported depression to
be associated with a 1.55 fold greater risk of being non-adherent
to ART (13). A study in Vietnam found that several clinical and
social factors were associated with depression among PLHIV, and
these factors included having a lower number of CD4 cells at the
start of ART, receiving ART in the clinic without HIV counseling
and testing (HCT) services, having a physical health problem, and
experiencing discrimination (14).
Stigma is another barrier for HIV patients. UNAIDS reported
in October 2017 that across 19 countries, one in five persons
living with HIV avoided going to health centers because they
feared stigma related to their HIV status (13). PLHIV are often
non-adherent to their ART to avoid being seen taking pills
and avoid being perceived as HIV-positive (15). People living
with HIV may experience social isolation, lose employment, and
family and friends as major sources of support (3). Previous
studies in Thailand, France, and South Africa have found a
positive association between SFS and ART adherence (15–17).
Persons living with HIV are highly susceptible to malnutrition
due to inadequate dietary intake, appetite loss, nutrition losses,
metabolic changes, and increased requirements for both macro
andmicronutrients (18). Those who are undernourished [defined
as body mass index (BMI) < 18.5 kg/m] are 10 times more likely
to be non-adherent to ART (19). In a prospective cohort study
in Haiti, receiving food assistance and subsequent improved
nutritional status was associated with improved adherence to
ART (18). Up to 60% of MSM HIV infected individuals
experience moderate to severe changes in body fat composition
(20, 21). It has been previously reported that MSM living
with HIV are more likely to experience high levels of body
dissatisfaction compared with heterosexual persons living with
HIV (22).
A lack of data exists on depression in Filipino MSM persons
living with HIV. The primary objective of this study was to
assess the prevalence of depression and its association with
ART adherence and with other risk factors, such as stigma,
low self-esteem, alcohol abuse, body image, nutritional status,
and low social and family support among Filipino MSM. We
hypothesized that these risk factors would be correlated and
associated with both depression and adherence.
METHODS
Study Design
This was a nested crosssectional study within an ongoing single-
arm, mobile health (mHealth) intervention study which used a
self-reported questionnaire for adherence to assess the impact of
the intervention on ART adherence.
Study Population
The inclusion criteria for participation in the nested study were
as follows: (1) adult PLHIV (age 18 years); (2) male subjects
who self-defined as having sex with males; (3) taking ART in
the sustained health initiatives of the Philippines (SHIP) clinic
in Manila; (4) enrolled into an existing, single-arm trial study:
the Connect for Life Mobile Phone Adherence Demonstration
Project (CFL) at the SHIP Clinic; (5) able to understand written
and spoken English. The exclusion criteria were the following: (1)
receiving primary HIV care at a facility other than SHIP; (2) late-
stage HIV and/or hospitalized; (3) previous psychiatric disease
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before diagnosis of HIV or any significant clinical neurological
disorder such as stroke or cerebral palsy.
Study Site
Sustained Health Initiatives of the Philippines Clinic is a low-
cost, private facility in Metro Manila, a city of just under 13
million people in the predominantly Catholic country of the
Philippines. SHIP Clinic provides HIV primary care and wrap-
around services to approximately 900 patients as of April 2021.
Between 2012 and 2018, SHIP was a satellite partner clinic of
the STI/AIDS Guidance Intervention and Prevention Unit at the
Philippine General Hospital (PGH-SAGIP), the largest hospital
in the country. Approximately 98% of clients of SHIP are MSM,
with an average age of 30 years at initial consultation. Most are
employed full- or part-time. The patients come from all regions
of Metro Manila and some live outside of Metro Manila in
other provinces.
Study Enrolment Procedures
Participants in the CFL study were approached to participate in
this nested study by a member of the study team during a routine
clinic visit and written informed consent was obtained.
Data Collection
Data were collected using a self-reported questionnaire,
including standardized data collection tools as described below,
designed, and implemented through Open Data Kit (ODK)
using an electronic tablet during a routine clinic visit. Trained
clinical research assistants were available to answer any queries
from participants while completing the questionnaire.
Antiretroviral therapy adherence data was extracted fromCFL
study records in which adherence was assessed using a self-
administered “Visual Analog scale” question of the percentage of
doses taken in the previous 30 days at four-time points, namely,
baseline [Week 0 (within 60 days from Screening)] and 12, 24,
and 48 weeks. Participants were defined as adherent at each time
point if the participant reported 95% of medications taken in the
prior 30 days.
CD4 data was extracted from participant records. In the study
site, ART initiation was recommended for all patients with an
AIDS-defining illness (Treat all policy), or when CD4 count is
below 500. CD4 count is performed every 6 months and the viral
load test is performed annually.
Depression/anxiety was assessed using the hospital anxiety
and depression scale (HADS), a self-administrated questionnaire
consisting of 14-items, seven questions assessing depressive
symptoms and seven assessing anxiety. Each item contains four
response options (from 0 to 3). The presence of anxiety or
depressive symptomswas defined as a score of HADS≥ 8 for each
(23–25). The HADS questionnaire had been validated in several
languages and countries, including the Philippines (26), and in
general practice and community settings (26, 27).
Alcohol abuse was measured using the alcohol use disorder
identification test (AUDIT) and is recommended for use in
the Philippines (28). The AUDIT is a 10-item, self-rating
questionnaire that assesses hazardous drinking, dependence
symptoms, and harmful alcohol use (29). The presence of
alcohol-related social problems and medical complications was
defined as an AUDIT score ≥ 8 (29, 30).
Social and family support was measured using the
multidimensional scale of perceived social support (MSPSS)
which measures the extent to which an individual perceives
social support from three different sides: family, friends, and a
significant other (31, 32). The scale is 12 items, with each item
using a 7-point Likert scale (32). MSPSS has been validated for
use in lower-middle-income countries (33–36). High levels of
perceived support were defined as total score 69–84; moderate
49–68; and low 12–48 (32, 36).
Stigma was measured using the Berger scale, designed to
determine stigma in HIV patients. It includes 40 items rated
FIGURE 1 | Study participant flow.
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on a 5-point scale from (37) assessing personalized stigma,
disclosure concerns, negative self-image, and concern with the
public attitude. Higher scores indicate more stigma (37, 38).
Self-esteem was measured using Rosenberg self-esteem scale
(RSES). It is a validated tool used to assess positive and negative
feelings of a patient to his own self (39, 40). It consists of
10 questions with a 4-point Likert scale ranging from very
negative (1) to very positive (4) (41, 42). Higher scores indicate
higher self-esteem.
Self-body image was measured by the body image quality of
life inventory (BIQLI), developed to monitor both positive and
negative effects of body image on a the psychosocial QOL of a
patient, which includes beliefs and emotions (43). This scale has
19 items, each using a 5-point Likert scale. BIQLI assesses the
specific domains of day-to-day emotions, self-esteem, sexuality,
social interest/avoidance, interpersonal relations, eating and
exercise, grooming habits, and general life satisfaction (44, 45).
Higher scores indicate high satisfaction with body image (44).
Anthropometry was conducted by trained clinical research
assistants at the time of the interview. Height was measured using
a stadiometer (model Seca 213) to the nearest 0.1 cm. Mid upper
arm circumference (MUAC) was measured using a non-elastic
plastic tape at the midway between the olecranon and acromion
process on the upper left arm. Body composition (body fat%,
lean bodymass, and visceral fat) wasmeasured using bioelectrical
impedance analysis (BIA) (model Tanita MC-780MA).
Ethics Statement
The primary intervention study (CFL) was approved by
the University of the Philippines Manila (reference number
UPMREB 2016-265-01) and London School of Hygiene and
Tropical Medicine (reference number 11631). This nested
crosssectional study was approved by Nagasaki University,
School of Tropical Medicine, and Global Health (reference
number 42) and the University of the Philippines Manila
(reference number UPMREB 2017-453-01).
Data Analysis
Adherence data were used from the same time point as the
current data collection. Data analysis was conducted using Stata
14.0. The proportion of study participants with depression or
anxiety (HADS scores ≥ 8) are reported as percentages with
corresponding 95% confidence intervals. Logistic regression
was used to investigate associations between depressive or
anxiety symptoms and being adherent/non-adherent as a binary
outcome. A p-value of 0.05 was considered as statistically
significant. Multivariable models were developed using a forward
stepwise approach from factors associated in univariable analyses
significant at p < 0.05 and models compared using likelihood
ratio (LR) tests.
RESULTS
Figure 1 shows the flow of persons potentially eligible and those
enrolled in the current study. Out of 342 participants in the
CFL study with routine clinic visits during the nested study
enrolment period, 193 Filipino MSM were enrolled between 7th
TABLE 1 | Demographic characteristics.
Demographic factor Freq. %
Total 193
Age
Mean (SD) 31.9 (5.90) –
Median (Range) 31 (22–53) –
Timepoint
First week 2 1.04%
12 weeks 4 2.07%
24 weeks 47 24.35%




Not reported 6 3.11%
Education level
College and higher 163 84.46%
High school and vocational 9 4.66%





No relationship 114 59.07%
In relationship 48 24.87%
Not reported 31 16.06%
Number of partners
Mean (SD) 3.1 (9.00) –
Disclosure status ¶
Disclosed 59 30.57%
Not disclosed 97 50.26%
















Not reported 8 4.15%
Frequency using condom
Always/most of the time 77 39.90%
Sometimes/never 110 56.99%
Not reported 6 3.11%
(Continued)
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TABLE 1 | Continued
Demographic factor Freq. %
Participate in commercial sex
No 179 92.75%
Yes 11 5.70%




Not reported 4 2.07%
¶Disclosure status: the process of revealing the HIV status of a person.
March and 30th September 2018 (Figure 1). The characteristics
of our study participants are shown in Table 1. The mean age
was 31.95 years (range 22–53, SD 5.90). Only 48 (24.9%) reported
being in a relationship. Most participants, 163 (84.5%) were
highly educated at college or higher level. Fifty-nine (30.6%)
had disclosed their HIV status and 91 (47.15%) reported using
condoms, with consistent condom use in 77 participants (39.0%).
The proportion reporting ever using IV drugs was 29 (15.0%).
The prevalence of non-adherence was 12.4% (24/193) with
125 (65%) of those adherent reporting 100% adherence in the
previous 30 days. The prevalence of depression was 21.8%
(42/193) and anxiety 37.3% (72/193) (Table 2). The prevalence
of poor SFS, poor self-esteem, and potential alcohol misuse was
34.7, 46.1, and 15.0%, respectively (Table 2).
No associations between age, timepoint, CD4 count, or
demographic variables (as per those in Table 1) with adherence
were observed (Supplementary Table 1).
Effects of Psychological, Social, and
Nutrition Factors on Non-adherence
For exposures with predefined cut-offs and analyzed as a
binary exposure, only high/moderate SFS compared with low
SFS was significantly associated with odds of non-adherence
(OR = 2.52; 95% CI:1.06–5.98) (Table 2). Although there
were more non-adherent participants amongst those who were
depressed (19.05%) compared with non-depressed (10.60%),
this did not reach statistical significance (Table 2). When
analyzed as continuous scores, there was good evidence of
an association between increased depression symptom score
and non-adherence (OR:1.13; 95% CI 1.02–1.26) as well as
poorer self-body image score [OR: 1.04; 95% CI (1.01–1.08)]
and decreased perceived SFS (OR = 1.03; 95% CI:1.00–1.07)
(Table 3). While higher BMI had weak evidence of association
(p = 0.0818) with non-adherence, there was no evidence for an
association between nutritional status assessed by MUAC (p =
0.4935) or with measures of body composition (Table 3).
We then investigated if any of the assessed psychosocial
and nutritional measures were also associated with depression
and could therefore be possible confounders of the association
between HADS score and non-adherence. Higher HADs score
for anxiety symptoms, higher stigma, lower self-esteem, lower
perceived social family support, and lower body image scores
were all significantly associated with depression as well as lower
measures of body fat (Supplementary Table 2).
When adjusting for SFS or body image, the association
between depression score and non-adherence, was not
statistically significant (Table 4). However, when comparing the
crude and adjusted models, no evidence of statistical difference
between the models was observed (LRT p-values 0.27 and 0.23;
Table 4).
DISCUSSION
To our knowledge, this is the first study in Filipino MSM living
with HIV to assess the prevalence of depressive symptoms with
other risk factors, which was observed to be 21.8%, that has
provided evidence to suggest an independent association between
non-adherence to ART and depressive symptoms, perceived
lower social family support, and poorer self-body image. The
prevalence of depressive symptoms in this study was lower than
that observed in a recent study of Chinese MSM living with
HIV (36%, 95% CI 1.03–1.05) (46) which also used HADS.
This difference may result from the higher educational status
and lower prevalence of drug use in our population compared
with the Chinese study population (46). In another study in
Tanzania, the prevalence of depression among MSM persons
living with HIV was also higher at 46.3% (47), possibly explained
by the study in Tanzania using the Patient health questionnaire
(PHQ) with cut-off point 4, which in a Swedish primary care
population diagnosed 30% more as depressed compared with
HADS (≥8) (48).
The prevalence of non-adherent persons in this study was
12.4%, lower than many other previous studies, but is perhaps
not unsurprising in this study in which all the participants were
recently enrolled into a mobile intervention study to improve
ART adherence and were relatively young, urban, and highly
educated. Furthermore, adherence may be higher in the newer
easier to take ARV regimens, and or the finding is similar
to a recent study in the urban Filipinos (4). In Cameroon,
the prevalence of ART non-adherence in 300 HIV infected
persons was 47.3% (49), defined using the Morisky scale ≥
1. While in 418 Ethiopians with HIV, the prevalence of self-
reported ART non-adherence (<95% of prescribed doses) over
the previous 7 days was 53.4% (50). Differences may result from
different methods of assessing and defining non-adherence, in
study population characteristics (e.g., level of education; 69%
in Ethiopia reported no education), and clinic settings, which
may affect communication and relationships with health care
providers (51, 52).
In this crosssectional study, we observed that an increase in
1 point of the HADS depression symptom score was associated
with a 13% increase in the odds of reporting non-adherence,
although the association with depression using HADS ≥ 8 did
not reach statistical significance. This is consistent with previous
findings in other populations. In a prospective study in 400
Ethiopians living with HIV, depression measured using a 13-
item scale, widely used in the HIV/AIDS literature (≥10 defined
as depressed), was significantly associated with non-adherence
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TABLE 2 | Prevalence and associations between depression, anxiety, self-esteem alcohol misuse, and social family support and ART adherence.
Adherent N = 169 (87.6%) Non-adherent N = 24 (12.4%) X2 P-valuea Total N = 193 OR (95% CI)
Depression N (%)
Not depressed (HADS score < 8) 135 (89.4%) 16 (10.60%) 0.142 151 (78.2%) 1.98 (0.78–5.02)
Depressed (HADS score ≥ 8) 34 (80.95%) 8 (19.05%) 42 (21.8%)
Anxiety N (%)
Not anxious (HADS score < 8)b 108 (89.26%) 13 (10.74%) 0.356 121 (62.6%) 1.5 (0.63–3.55)
Anxious (HADS score ≥ 8) 61 (84.72%) 11 (15.28%) 72 (37.3%)
Self-esteem N (%)
Good self-esteem (RSES ≥ 21)c 94 (90.38%) 10 (9.62%) 0.199 104 (53.9%) 1.75 (0.74–4.17)
Poor self-esteem (RSES < 21) 75 (84.27%) 14 (15.73%) 89 (46.1%)
Alcohol behavior N (%)
No alcohol problem (AUDIT < 8)d 143 (87.20%) 21 (12.80%) 0.711 164 (84.9%) 0.79 (0.22–2.83)
Alcohol problem (AUDIT ≥ 8) 26 (89.66%) 3 (10.34%) 29 (15%)
Social and family support N (%)
Good/Moderate support (MSPSS ≥ 49)e 115 (91.27%) 11 (8.73%) 0.032* 126 (65.2%) 2.52 (1.06–5.98)
Less support (MSPSS < 49) 54 (80.60%) 13 (19.4%) 67 (34.7%)
aX2, chi-square significance test, bHADS, Hospital Anxiety and Depression Scale; cRSES, Rosenberg Self-Esteem Scale; dAUDIT, Alcohol Use Identifier Test; eMSPSS, Multidimensional
Scale of Perceived Social Support. Bold values indicate that p-value < 0.05.
assessed using a self-reported scale over the last 7 days (OR
2.13; 95% CI: 1.18–3.81) (53). Two crosssectional studies, one
in Thailand in 379 participants with depression assessed using
the Beck depression inventory II (≥14 defined as depressed) was
associated with non-adherence measured by self-reported scale
over 30 days (<95%) (OR 4.68; 95% CI: 2.78–7.88) (54), and
in Cameron in 300 participants, depression using the patient
health question-9 (≥10 defined as depressed) was associated
with adherence assessed by Morisky scale (≥1) (OR 5.04; CI:
2.84–8.97) (49).
Social family support and body image dissatisfaction were also
strongly associated with non-adherence. This is consistent with
the findings in the above Ethiopian study in which participants
with higher perceived social family support were 1.82 times more
likely to be adherent to ART (OR: 1.82, 95% CI:1.04–3.21) (53).
Similar findings were observed In India, among 279, persons
with high SFS score were 1.96 times more likely to be adherent
(OR: 1.96; CI: 0.94–4.08) (55). Also, in a community-based study
in 233 Nepalese living with HIV, negative emotional distance
from family was associated with ART non-adherence (OR= 3.38,
CI 1.28–8.91) (56). Therefore, social family support should be
considered to be used to identify and prioritize those at high risk
of non-adherence.
Body image dissatisfaction has been previously reported to
have an adverse effect on ART adherence level (44). Generally,
MSM, regardless of their HIV status, are more likely to have a
high level of body dissatisfaction compared with heterosexuals
(22, 57). Also, ART can cause body fat changes due to
lipodystrophy (21, 44). Body image dissatisfaction may be an
important indicator of non-adherence and cluster with other
high-risk behaviors and psychosocial impacts that may benefit
from interventions, including poor ART adherence (44, 45,
58), increased sexual behaviors that can transmit HIV (58),
elevated levels of depressive symptoms (44, 58–60), increased
methamphetamine use (61), and low self-esteem (62). In an
Italian cohort study persons who had body tissue changes as a
side effect of ART were almost five times more likely to be non-
adherent (OR:4.67, 95% CI, 1.01–22.4) (63), and in an American
cohort of 1,671 women self-perception of central fat gain was
associated with a 1.5-fold increased odds of ART non-adherence
(64). Finally, in a crosssectional study testing the impact of
depression on the relationship between HAART adherence and
body dissatisfaction in 124 HIV gay and heterosexual men,
body dissatisfaction and depression independently predicted
HAART non-adherence (44). Physical exercise might be a good
intervention to improve depressive and anxiety symptoms and
consequently adherence. A longitudinal study of three cohort
studies done in the Netherlands among 7,076 participants
showed that people who exercised were 1.47 times likely to
recover from depression and anxiety (65).
There were several limitations of this study. Adherence
was measured by self-report. Therefore, recall bias and social
desirability bias may lead the participants to overreport their
adherence level. Also, this crosssectional study was done
within an intervention study with the aim of improving
treatment adherence, and thus is not representative of those
in standard care. Hence, level of adherence might be already
enhanced compared with the general HIV population in the
Philippines. The study population in SHIP clinic are also
more highly educated than the general population in the
Philippines and may not represent the general MSM population
in the Philippines.
CONCLUSIONS
This study was the first to assess the association between
depression or other risk factors and ART non-adherence
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TABLE 3 | Social, psychological, and nutrition factors and ART non-adherence as continuous measure.
Risk factor Adherent N = 169 Non-adherent N = 24 Crude OR (95%CI)
Social and psychological factors
Age (years) 0.97 (0.90–1.05)
Mean (95% CI) 32.05 (31.15–32.96) 31.20 (28.94–33.47)
Depression HADS score 1.13 (1.02–1.26)
Mean (95% CI) 4.46 (3.92–5.00) 6.42 (4.54–8.30)
Anxiety HADS score 1.06 (0.97–1.16)
Mean (95% CI) 6.62 (5.97–7.28) 7.79 (5.73–9.86)
Self-esteem score 1.06 (0.99–1.14)
Mean (95% CI) 21.31 (20.43–22.18) 19.21 (16.51–21.90)
Social and family support score 1.03 (1.00–1.07)
Mean (95% CI) 52.79 (50.87–54.70) 46.33 (40.18–52.49)
Alcohol misuse score 1.01 (0.93–1.11)
Mean (95% CI) 3.63 (2.89–4.36) 3.92 (2.59–5.24)
Stigma score 0.99 (0.97–1.00)
Mean (95% CI) 116.88 (25.81) 108.29 (28.06)
BIQLI score 1.04 (1.01–1.08)
Mean (95% CI) 70.17 (68.47–71.86) 62.88 (57.49–70.25)
Nutritional factors
BMI (kg/m2) 1.13 (0.98–1.29)
Mean (95% CI) 23.71 (23.22–24.20) 24.92 (23.67–2618)
MUAC (cm) 1.04 (0.93–1.16)
Mean (95% CI) 30.03 (29.42–30.62) 30.62 (28.92–32.32)
Body compositionsa
Waist/hip ratio 3.89 (0.00–3279.80)
Mean (95% CI) 0.91 (0.90–0.92) 0.92 (0.89–0.94)
Total body fat (%) 1.02 (0.95–1.10)
Mean (95% CI) 17.42 (16.52–18.31) 18.04 (15.37–20.70)
Total lean body mass (%) 1.00 (0.96–1.05)
Mean (95% CI) 77.54 (76.03–79.05) 77.83 (75.30–80.36)
Visceral fat (%) 1.05 (0.90–1.22)
Mean (95% CI) 5.02 (4.59–5.44) 5.38 (4.12–6.63)
Central fat mass (kg) 1.01 (0.96–1.08)
Mean (95% CI) 19.54 (18.43–20.64) 20.25 (16.81–23.69
Clinical/HIV associatedb
Cd4 count (cells per µI) 1.005 (0.99–1.02)
Mean (95% CI)2 493.21 (456.87–529.55) 529.73 (423.86–634.89)
Measurement of nutritional factors was missing for 1 person for BMI, afor MUAC and 2 for body composition measurements—all in the adherent group; bFour patients did not have
data for CD4 count—all in adherent group.
TABLE 4 | Comparison of models of association between depression and non-adherence with and without adjustment for potential confounders.
Model OR for HADS score Wald test p-value LRT p-value comparing models
Depression score Crude association 1.13 (1.02–1.26) 0.0159 NA
Depression score + social/family support 1.09 (0.96–1.24) 0.179 0.27a
Depression score + body image 1.08 (0.94–1.24) 0.255 0.23b
aComparing model including depression score and SFS score with depression score only. bComparing model including depression score and BI score with depression score only. Bold
values indicate that p-value < 0.05.
among MSM persons living with HIV in the Philippines.
The findings of this study documented that depression
is a relatively common symptom among MSM persons
with HIV. Comprehensive mental health services beyond
post-HIV testing counseling may increase adherence to
ART and improve HIV treatment outcome. This can be
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done through routine screening for depression and anxiety
symptoms using standardized validated tools like HADS,
which can enable early identification of patients with mild
or moderate symptoms. Simple interventions such as peer
support, supervised by clinic program staff may help prevent the
progression of symptoms and the development of complications.
Patients with severe symptoms should be ideally referred to
psychiatrists (if available) for further evaluation and care.
Previous studies have shown that peer support can improve
depressive symptoms more than ordinary care, as PLWHIV
may prefer to share their experiences with others who are
facing similar obstacles rather than reporting their psychological
difficulties to psychiatrists or doctors (66, 67). In the SHIP
clinic, doctors have subsequently started to conduct routine
depression/anxiety screening using this tool, and they report
that it enables patients to express their feelings and concerns
and helps develop a stronger relationship between doctors
and patients. Further prospective studies are needed to
address the causal/reverse causal pathway between depression
and non-adherence.
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